The DNMT3A rs227698 polymorphism exhibited an association with tumor response to treatment, which was assessed through the percentage of patients achieving complete or partial remission as per the Response Evaluation Criteria in Solid Tumors classification [16]. This evidence concerns the gene DNMT3A and neoplasm.